Anti-inflammatory activity of cinnamon (C. zeylanicum and C. cassia) extracts - identification of E-cinnamaldehyde and o-methoxy cinnamaldehyde as the most potent bioactive compounds - PubMed (original) (raw)

Comparative Study

doi: 10.1039/c4fo00680a.

Affiliations

• PMID: 25629927
• DOI: 10.1039/c4fo00680a

Comparative Study

Anti-inflammatory activity of cinnamon (C. zeylanicum and C. cassia) extracts - identification of E-cinnamaldehyde and o-methoxy cinnamaldehyde as the most potent bioactive compounds

Dhanushka Gunawardena et al. Food Funct. 2015 Mar.

Abstract

Chronic inflammation is a contributing factor in many age-related diseases. In a previous study, we have shown that Sri Lankan cinnamon (C. zeylanicum) was one of the most potent anti-inflammatory foods out of 115 foods tested. However, knowledge about the exact nature of the anti-inflammatory compounds and their distribution in the two major cinnamon species used for human consumption is limited. The aim of this investigation was to determine the anti-inflammatory activity of C. zeylanicum and C. cassia and elucidate their main phytochemical compounds. When extracts were tested in LPS and IFN-γ activated RAW 264.7 macrophages, most of the anti-inflammatory activity, measured by down-regulation of nitric oxide and TNF-α production, was observed in the organic extracts. The most abundant compounds in these extracts were E-cinnamaldehyde and o-methoxycinnamaldehyde. The highest concentration of E-cinnamaldehyde was found in the DCM extract of C. zeylanicum or C. cassia (31 and 34 mg g(-1) of cinnamon, respectively). When these and other constituents were tested for their anti-inflammatory activity in RAW 264.7 and J774A.1 macrophages, the most potent compounds were E-cinnamaldehyde and o-methoxycinnamaldehyde, which exhibited IC₅₀ values for NO with RAW 264.7 cells of 55 ± 9 μM (7.3 ± 1.2 μg mL(-1)) and 35 ± 9 μM (5.7 ± 1.5 μg mL(-1)), respectively; and IC₅₀ values for TNF-α of 63 ± 9 μM (8.3 ± 1.2 μg mL(-1)) and 78 ± 16 μM (12.6 ± 2.6 μg mL(-1)), respectively. If therapeutic concentrations can be achieved in target tissues, cinnamon and its components may be useful in the treatment of age-related inflammatory conditions.

PubMed Disclaimer

Similar articles

• Cinnamon extracts, _trans_-cinnamaldehyde and _trans_-cinnamic acid inhibit HDAC 1 activity.
  Koyu H, Istanbullu H, Turunc Ozoglu SE, Kaya Temiz T. Koyu H, et al. Food Funct. 2024 Aug 27;15(17):8689-8699. doi: 10.1039/d4fo02764g. Food Funct. 2024. PMID: 39145543
• Simultaneous Estimation of Cinnamaldehyde and Eugenol in Essential Oils and Traditional and Ultrasound-Assisted Extracts of Different Species of Cinnamon Using a Sustainable/Green HPTLC Technique.
  Foudah AI, Shakeel F, Alqarni MH, Ross SA, Salkini MA, Alam P. Foudah AI, et al. Molecules. 2021 Apr 3;26(7):2054. doi: 10.3390/molecules26072054. Molecules. 2021. PMID: 33916710 Free PMC article.
• Suppression effect of Cinnamomum cassia bark-derived component on nitric oxide synthase.
  Lee HS, Kim BS, Kim MK. Lee HS, et al. J Agric Food Chem. 2002 Dec 18;50(26):7700-3. doi: 10.1021/jf020751f. J Agric Food Chem. 2002. PMID: 12475291
• Chemistry, biogenesis, and biological activities of Cinnamomum zeylanicum.
  Jayaprakasha GK, Rao LJ. Jayaprakasha GK, et al. Crit Rev Food Sci Nutr. 2011 Jul;51(6):547-62. doi: 10.1080/10408391003699550. Crit Rev Food Sci Nutr. 2011. PMID: 21929331 Review.
• [Research progress of trans-cinnamaldehyde pharmacological effects].
  Zhang LQ, Zhang ZG, Fu Y, Xu Y. Zhang LQ, et al. Zhongguo Zhong Yao Za Zhi. 2015 Dec;40(23):4568-72. Zhongguo Zhong Yao Za Zhi. 2015. PMID: 27141665 Review. Chinese.

Cited by

• Silver Nanoparticles Biofabricated from Cinnamomum zeylanicum Reduce IL-6, IL-18, and TNF-ɑ in Female Rats with Polycystic Ovarian Syndrome.
  Alwan SH, Al-Saeed MH. Alwan SH, et al. Int J Fertil Steril. 2023 Jan 1;17(1):80-84. doi: 10.22074/ijfs.2022.539396.1189. Int J Fertil Steril. 2023. PMID: 36617208 Free PMC article.
• Antioxidant and anti-inflammatory effects of polyphenols extracted from Ilex latifolia Thunb.
  Zhang TT, Hu T, Jiang JG, Zhao JW, Zhu W. Zhang TT, et al. RSC Adv. 2018 Feb 14;8(13):7134-7141. doi: 10.1039/c7ra13569f. eCollection 2018 Feb 9. RSC Adv. 2018. PMID: 35540363 Free PMC article.
• Very Early Onset Inflammatory Bowel Disease: A Clinical Approach With a Focus on the Role of Genetics and Underlying Immune Deficiencies.
  Ouahed J, Spencer E, Kotlarz D, Shouval DS, Kowalik M, Peng K, Field M, Grushkin-Lerner L, Pai SY, Bousvaros A, Cho J, Argmann C, Schadt E, Mcgovern DPB, Mokry M, Nieuwenhuis E, Clevers H, Powrie F, Uhlig H, Klein C, Muise A, Dubinsky M, Snapper SB. Ouahed J, et al. Inflamm Bowel Dis. 2020 May 12;26(6):820-842. doi: 10.1093/ibd/izz259. Inflamm Bowel Dis. 2020. PMID: 31833544 Free PMC article. Review.
• Cinnamomum cassia exhibits antileishmanial activity against Leishmania donovani infection in vitro and in vivo.
  Afrin F, Chouhan G, Islamuddin M, Want MY, Ozbak HA, Hemeg HA. Afrin F, et al. PLoS Negl Trop Dis. 2019 May 9;13(5):e0007227. doi: 10.1371/journal.pntd.0007227. eCollection 2019 May. PLoS Negl Trop Dis. 2019. PMID: 31071090 Free PMC article.
• Cinnamon effects on metabolic syndrome: a review based on its mechanisms.
  Mollazadeh H, Hosseinzadeh H. Mollazadeh H, et al. Iran J Basic Med Sci. 2016 Dec;19(12):1258-1270. doi: 10.22038/ijbms.2016.7906. Iran J Basic Med Sci. 2016. PMID: 28096957 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Royal Society of Chemistry

• Medical

  • MedlinePlus Health Information